
According to Benzinga Pro, during Q4, Harmony Biosciences (NASDAQ:HRMY) earned $22.71 million, a 336.11% increase from the preceding quarter. Harmony Biosciences also posted a total of $91.21 million in sales, a 12.98% increase since Q3. In Q3, Harmony Biosciences brought in $80.73 million in sales but lost $9.62 million in earnings.